The Filing Desk

Cronos Group vs Niagen Bioscience

Cronos Group CRON · Niagen Bioscience NAGE · Personal Care Products

Cronos Group reported revenue of $147 million in fiscal 2025, about the same as Niagen Bioscience's $129 million in fiscal 2025. Cronos Group's revenue grew 24.6% in its latest year, and Niagen Bioscience's grew 29.9%. Cronos Group had an operating margin of -11.9%, against 12.6% at Niagen Bioscience.

Side by side

Cronos GroupNiagen Bioscience
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$147M$129M
Revenue growth24.6%29.9%
Revenue growth a year, last 5 years25.7%16.9%
Gross margin42.8%64.3%
Operating margin−11.9%12.6%
Net margin−6.4%13.4%
Free cash flow$0M—
Free cash flow margin0.1%—
Return on capital——
Net debt to EBITDA—−3.8x
Dividends and buybacks$10M$0M
Change in diluted share count−0.5%9.4%
Last close$3.08$1.87
P/E at the last close18.1×15.6×
Insider trades, last 12 months——
Piotroski F-score—6 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Cronos GroupNiagen Bioscience
Operating margin
Percent of revenue
Cronos GroupNiagen Bioscience
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Cronos GroupNiagen Bioscience

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Cronos Group and Niagen Bioscience pages.